This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Warner Chilcott Company, LLC. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Dzelal Serdarevic: Innovator in Pharmaceutical Treatments
Introduction
Dzelal Serdarevic is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of overactive bladder conditions. His innovative work has led to the development of a specific medication that addresses a common yet challenging health issue.
Latest Patents
Dzelal Serdarevic holds 1 patent for his invention titled "Darifenacin for use in the treatment of urgency induced by overactive bladder." This invention provides the use of darifenacin, or a pharmaceutically acceptable derivative thereof, in the manufacture of a medicament aimed at reducing urgency in patients suffering from overactive bladder.
Career Highlights
Throughout his career, Dzelal has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Warner Chilcott Company, LLC and Novartis International Pharmaceutical, Ltd. His experience in these organizations has contributed to his expertise and innovative capabilities in drug development.
Collaborations
Dzelal has collaborated with several professionals in his field, including Enrico Colli and Paul Quinn. These partnerships have likely enhanced his research and development efforts, leading to successful outcomes in his projects.
Conclusion
Dzelal Serdarevic's contributions to pharmaceutical innovations, particularly in the treatment of overactive bladder, highlight his role as a significant inventor in the industry. His work continues to impact the lives of many patients seeking relief from this condition.